Acebutolol
|
Acebutolol may decrease symptoms of hypoglycemia and increase the time required for the body to compensate for hypoglycemia.
|
Acetylsalicylic acid
|
Acetylsalicylic acid increases the effect of the sulfonylurea, tolazamide.
|
Amifostine
|
Additive hypotensive effects may occur. At chemotherapeutic doses of Amifostine, Tolazamide should be withheld for 24 hours prior to Amifostine administration. Use caution at lower doses of Amifostine.
|
Atenolol
|
The beta-blocker, atenolol, may decrease symptoms of hypoglycemia.
|
Bisoprolol
|
The beta-blocker, bisoprolol, may decrease symptoms of hypoglycemia.
|
Carvedilol
|
The beta-blocker, carvedilol, may decrease symptoms of hypoglycemia.
|
Chloramphenicol
|
Chloramphenicol may increase the effect of sulfonylurea, tolazamide.
|
Clofibrate
|
Clofibrate may increase the effect of sulfonylurea, tolazamide.
|
Esmolol
|
The beta-blocker, esmolol, may decrease symptoms of hypoglycemia.
|
Labetalol
|
The beta-blocker, labetalol, may decrease symptoms of hypoglycemia.
|
Metoprolol
|
The beta-blocker, metoprolol, may decrease symptoms of hypoglycemia.
|
Nadolol
|
The beta-blocker, nadolol, may decrease symptoms of hypoglycemia.
|
Oxprenolol
|
The beta-blocker, oxprenolol, may decrease symptoms of hypoglycemia.
|
Phenylbutazone
|
Phenylbutazone increases the effect of the hypoglycemic agent
|
Pindolol
|
The beta-blocker, pindolol, may decrease symptoms of hypoglycemia.
|
Propranolol
|
The beta-blocker, propranolol, may decrease symptoms of hypoglycemia.
|
Rifampin
|
Rifampin may decrease the effect of sulfonylurea, tolazamide.
|
Rituximab
|
Additive hypotensive effects may occur. Consider withholding Tolazamide for 12 hours prior to administration of Rituximab.
|
Somatropin recombinant
|
Somatropin may antagonize the hypoglycemic effect of Tolazamide. Dose adjustments of Tolazamide may be required.
|
Timolol
|
The beta-blocker, timolol, may decrease symptoms of hypoglycemia.
|